Advertisement
Biofrontera Inc.

Biofrontera Inc. (BFRIW) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

BFRIWNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.03
$0.004(17.26%)
U.S. Market opens in 1h 29m
Advertisement

Biofrontera Inc. (BFRIW)

Meyka AI Score

Z

Key Financials

Market Cap9.8M
P/E Ratio-0.93
EPS (TTM)$-1.30
ROE-4.77%
Fundamental Analysis

AI Price Forecasts

1 Month$0.07
3 Months$0.13
1 Year Target$0.87

BFRIW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRIW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.93 and a market capitalization of 9.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
17.26%
5-Day Change
17.26%
1-Month Change
-17.96%
3-Month Change
-42.39%
6-Month Change
-62.14%
Year-to-Date (YTD) Change
-70.56%
1-Year Change
-77.88%
3-Year Change
-66.88%
5-Year Change
-97.95%
All-Time (Max) Change
-97.95%

Contact Information

781-245-1325
120 Presidential Way, Woburn, DE, 01801

Company Facts

920 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions